[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP4200288A4 - Compounds and methods for treating autoimmune disorders by targeting hla-dq2 - Google Patents

Compounds and methods for treating autoimmune disorders by targeting hla-dq2

Info

Publication number
EP4200288A4
EP4200288A4 EP21859188.1A EP21859188A EP4200288A4 EP 4200288 A4 EP4200288 A4 EP 4200288A4 EP 21859188 A EP21859188 A EP 21859188A EP 4200288 A4 EP4200288 A4 EP 4200288A4
Authority
EP
European Patent Office
Prior art keywords
compounds
methods
autoimmune disorders
treating autoimmune
targeting hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21859188.1A
Other languages
German (de)
French (fr)
Other versions
EP4200288A1 (en
Inventor
Robert B Perni
Ryan Schutte
James M Siedlecki
Asha Ghevde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomolecular Therapeutics Inc
Original Assignee
Immunomolecular Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomolecular Therapeutics Inc filed Critical Immunomolecular Therapeutics Inc
Publication of EP4200288A1 publication Critical patent/EP4200288A1/en
Publication of EP4200288A4 publication Critical patent/EP4200288A4/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP21859188.1A 2020-08-21 2021-08-20 Compounds and methods for treating autoimmune disorders by targeting hla-dq2 Pending EP4200288A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063068631P 2020-08-21 2020-08-21
PCT/US2021/046860 WO2022040508A1 (en) 2020-08-21 2021-08-20 Compounds and methods for treating autoimmune disorders by targeting hla-dq2

Publications (2)

Publication Number Publication Date
EP4200288A1 EP4200288A1 (en) 2023-06-28
EP4200288A4 true EP4200288A4 (en) 2024-10-30

Family

ID=80270497

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21859188.1A Pending EP4200288A4 (en) 2020-08-21 2021-08-20 Compounds and methods for treating autoimmune disorders by targeting hla-dq2

Country Status (3)

Country Link
US (1) US11939300B2 (en)
EP (1) EP4200288A4 (en)
WO (1) WO2022040508A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068170A2 (en) * 2002-02-14 2003-08-21 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
WO2007075783A2 (en) * 2005-12-22 2007-07-05 Wyeth Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068170A2 (en) * 2002-02-14 2003-08-21 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
WO2007075783A2 (en) * 2005-12-22 2007-07-05 Wyeth Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022040508A1 *

Also Published As

Publication number Publication date
US11939300B2 (en) 2024-03-26
WO2022040508A1 (en) 2022-02-24
US20220055994A1 (en) 2022-02-24
EP4200288A1 (en) 2023-06-28

Similar Documents

Publication Publication Date Title
IL304429A (en) Methods and compositions for treatment of epileptic disorders
IL289970A (en) Compositions and methods for treating autoimmune disorders
IL289173A (en) Compositions and methods for treating cns disorders
SG11202009371WA (en) Methods for treating atopic dermatitis by administering an il-4r inhibitor
IL289172A (en) Compositions and methods for treating cns disorders
IL291687A (en) Methods for treating myelofibrosis and related conditions
IL270114B1 (en) Methods and compositions for treating neurological disorders
IL288655A (en) Compositions and methods for treating central nervous system disorders
EP3826650A4 (en) Methods of treating neurological disorders
IL294594A (en) Methods for treating pemphigus disorders
IL281736A (en) Methods of treating myeloproliferative disorders
IL275985A (en) Compositions and methods for treating retinal disorders
EP3826649A4 (en) Methods of treating neurological disorders
SG11202011151VA (en) Compositions and methods for reducing spliceopathy and treating rna dominance disorders
EP4188368A4 (en) Compositions and methods for treating diseases and disorders
IL313097A (en) Methods of treating cns disorders
IL292678A (en) Methods of treating depressive disorders
GB201914034D0 (en) Treatment of neurological disorders
IL286571A (en) Compositions and methods for treating neurodegenerative disorders
IL292186A (en) Compositions and methods for treating blood disorders
EP4200288A4 (en) Compounds and methods for treating autoimmune disorders by targeting hla-dq2
IL313539A (en) Methods for treating neurological disorders
IL311852A (en) Compositions and methods for treating neurological disorders
IL289018A (en) Methods for treating neurodegenerative disorders
IL291639A (en) Method for treating mood disorders

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230317

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C07D0307330000

Ipc: C07D0237280000

A4 Supplementary search report drawn up and despatched

Effective date: 20240930

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 37/02 20060101ALI20240925BHEP

Ipc: A61K 31/502 20060101ALI20240925BHEP

Ipc: C07D 405/06 20060101ALI20240925BHEP

Ipc: C07D 403/04 20060101ALI20240925BHEP

Ipc: C07D 401/12 20060101ALI20240925BHEP

Ipc: C07D 405/04 20060101ALI20240925BHEP

Ipc: C07D 237/28 20060101AFI20240925BHEP